Article Information
History
- January 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anne L. Wyllie1,*,#,
- Devyn Yolda-Carr1,
- Maikel S. Hislop1,
- Sidiya Mbodj1,
- Loren Wurst1,
- Pari Waghela1,
- Ronika Alexander-Parrish2,
- Lindsay R. Grant2,
- Adriano Arguedas2,
- Bradford D. Gessner2 and
- Daniel M. Weinberger1,*
- 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA;
- 2Pfizer Inc, Collegeville, PA, 19426, USA
- ↵#Corresponding author:
Anne Wyllie, PhD, awyllie{at}gmail.com, Yale School of Public Health, LEPH 823, 60 College St, New Haven, CT 06510, USA
↵* These authors contributed equally to the study